The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 412.90
Bid: 412.80
Ask: 413.00
Change: 2.40 (0.58%)
Spread: 0.20 (0.048%)
Open: 412.30
High: 414.60
Low: 410.50
Prev. Close: 410.50
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Jun 2016 07:00

RNS Number : 5693C
Rentokil Initial PLC
28 June 2016
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

 

Rentokil Initial plc

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act 2006.

 

Pursuant to (i) and (iii) above

 

3. Name of person discharging managerial responsibilities/director

 

Jeremy Townsend (Director)

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

Not applicable

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

Pursuant to 3 above

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

Ordinary shares of 1 pence each

 

7. Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

 

Not applicable

 

8 State the nature of the transaction

 

Exercise of Performance share plan award 2013 - Final vested award 30 April 2016 - 492,538

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

492,538 - Performance shares plan award 2013

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.02693%

  

11. Number of shares, debentures or financial instruments relating to shares disposed

 

232,307 ordinary shares of 1p each to satisfy tax liability and dealing costs

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

 

0.01270%

 

13. Price per share or value of transaction

 

180.2p

 

14. Date and place of transaction

 

27 June 2016, London

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

488,600 ordinary shares of 1p each - 0.02671%

 

16. Date issuer informed of transaction

 

27 June 2016

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17. Date of grant

 

N/A

 

18. Period during which or date on which it can be exercised

 

N/A

 

19. Total amount paid (if any) for grant of the option

 

N/A

  

20. Description of shares or debentures involved (class and number)

 

N/A

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

N/A

 

22. Total number of shares or debentures over which options held following notification

 

N/A

 

23. Any additional information

Sale of 232,307 ordinary shares to satisfy tax liability and dealing costs

24. Name of contact and telephone number for queries

 

Daragh Fagan, Company Secretary - +44 (0)1276 607444

 

25. Name of authorised official of issuer responsible for making notification and date of notification

 

Daragh Fagan, General Counsel and Company Secretary

28 June 2016

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDDGDLSSDBGLI
Date   Source Headline
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.